How does nintedanib work? Exploring its multi-target mechanism
•
5 min read
In clinical trials, nintedanib has been shown to significantly reduce the rate of lung function decline in patients with idiopathic pulmonary fibrosis (IPF) and other progressive fibrosing interstitial lung diseases (ILDs). Nintedanib works by blocking multiple signaling pathways crucial for the development of fibrosis and angiogenesis.
